Peter Nygren

Induction of mitochondrial dysfunction as a strategy for targeting tumour cells in metabolically compromised microenvironments

Xiaonan Zhang, Mårten Fryknäs, E Hernlund et al. · Nature Communications · 2014 · 253 citations · Full text

Medicine, Cancer Biology, Oncology +17

Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA)

Rolf Larsson, Jörgen Kristensen, Charlotta Sandberg et al. · International Journal of Cancer · 1992 · 246 citations

Medicine, Oncology, Pharmacology +12

The fluorometric microculture cytotoxicity assay

Elin Lindhagen, Peter Nygren, Rolf Larsson · Nature Protocols · 2008 · 236 citations

Dentistry, Cell Biology, Toxicology +6

Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data

Anne von Heideman, Åke Berglund, Rolf Larsson et al. · Cancer Chemotherapy and Pharmacology · 2009 · 194 citations · Full text

Medicine, Oncology, Pharmacology +16

Loss of cancer drug activity in colon cancer HCT-116 cells during spheroid formation in a new 3-D spheroid cell culture system

Henning Karlsson, Mårten Fryknäs, Rolf Larsson et al. · Experimental Cell Research · 2012 · 180 citations

Medicine, Oncology, Pharmacology +15